Theradex has a long history of experience in providing support for pharmacokinetic (PK) studies for early phase oncology clinical trials across a wide range of compounds and biologics. Our in-house team of scientific (PhD), biostatistic and project management experts have experience in delivering all key components of a successful PK report which include: